Edwards Lifesciences Cash on Hand 2010-2024 | EW
Edwards Lifesciences cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Edwards Lifesciences cash on hand for the quarter ending December 31, 2024 was $4.446B, a 138.54% increase year-over-year.
- Edwards Lifesciences cash on hand for 2023 was $1.645B, a 35.32% increase from 2022.
- Edwards Lifesciences cash on hand for 2022 was $1.215B, a 17.15% decline from 2021.
- Edwards Lifesciences cash on hand for 2021 was $1.467B, a 4.58% increase from 2020.
| Edwards Lifesciences Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $1,645 |
| 2022 | $1,215 |
| 2021 | $1,467 |
| 2020 | $1,403 |
| 2019 | $1,517 |
| 2018 | $957 |
| 2017 | $1,338 |
| 2016 | $1,271 |
| 2015 | $1,225 |
| 2014 | $1,439 |
| 2013 | $937 |
| 2012 | $521 |
| 2011 | $451 |
| 2010 | $396 |
| 2009 | $334 |
| Edwards Lifesciences Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-09-30 | $4,446 |
| 2024-06-30 | $1,990 |
| 2024-03-31 | $1,698 |
| 2023-12-31 | $1,633 |
| 2023-09-30 | $1,864 |
| 2023-06-30 | $1,509 |
| 2023-03-31 | $1,254 |
| 2022-12-31 | $1,215 |
| 2022-09-30 | $1,739 |
| 2022-06-30 | $1,516 |
| 2022-03-31 | $1,496 |
| 2021-12-31 | $1,467 |
| 2021-09-30 | $1,795 |
| 2021-06-30 | $1,561 |
| 2021-03-31 | $1,331 |
| 2020-12-31 | $1,403 |
| 2020-09-30 | $1,295 |
| 2020-06-30 | $1,164 |
| 2020-03-31 | $1,031 |
| 2019-12-31 | $1,517 |
| 2019-09-30 | $1,357 |
| 2019-06-30 | $934 |
| 2019-03-31 | $963 |
| 2018-12-31 | $957 |
| 2018-09-30 | $1,596 |
| 2018-06-30 | $1,401 |
| 2018-03-31 | $1,499 |
| 2017-12-31 | $1,338 |
| 2017-09-30 | $1,403 |
| 2017-06-30 | $1,132 |
| 2017-03-31 | $918 |
| 2016-12-31 | $1,271 |
| 2016-09-30 | $1,200 |
| 2016-06-30 | $1,060 |
| 2016-03-31 | $952 |
| 2015-12-31 | $1,225 |
| 2015-09-30 | $1,251 |
| 2015-06-30 | $1,409 |
| 2015-03-31 | $1,371 |
| 2014-12-31 | $1,439 |
| 2014-09-30 | $1,515 |
| 2014-06-30 | $1,484 |
| 2014-03-31 | $832 |
| 2013-12-31 | $937 |
| 2013-09-30 | $758 |
| 2013-06-30 | $575 |
| 2013-03-31 | $558 |
| 2012-12-31 | $521 |
| 2012-09-30 | $623 |
| 2012-06-30 | $506 |
| 2012-03-31 | $410 |
| 2011-12-31 | $451 |
| 2011-09-30 | $451 |
| 2011-06-30 | $468 |
| 2011-03-31 | $434 |
| 2010-12-31 | $396 |
| 2010-09-30 | $361 |
| 2010-06-30 | $320 |
| 2010-03-31 | $321 |
| 2009-12-31 | $334 |
| 2009-09-30 | $290 |
| 2009-06-30 | $188 |
| 2009-03-31 | $150 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $44.064B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $216.048B | 99.11 |
| Thermo Fisher Scientific (TMO) | United States | $205.720B | 24.60 |
| Alcon (ALC) | Switzerland | $44.180B | 29.56 |
| IDEXX Laboratories (IDXX) | United States | $37.082B | 42.44 |
| DexCom (DXCM) | United States | $34.912B | 54.15 |
| IQVIA Holdings (IQV) | United States | $34.165B | 18.93 |
| Mettler-Toledo (MTD) | United States | $27.257B | 31.66 |
| Waters (WAT) | United States | $22.611B | 32.08 |
| STERIS (STE) | Ireland | $21.693B | 24.81 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.328B | 0.00 |
| Hologic (HOLX) | United States | $14.433B | 15.57 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.462B | 13.82 |
| Penumbra (PEN) | United States | $11.675B | 105.62 |
| Sysmex ADR (SSMXY) | Japan | $11.519B | 36.12 |
| Globus Medical (GMED) | United States | $11.454B | 26.79 |
| Masimo (MASI) | United States | $9.488B | 45.91 |
| Glaukos (GKOS) | United States | $8.676B | 0.00 |
| Teleflex (TFX) | United States | $8.134B | 12.97 |
| Inari Medical (NARI) | United States | $4.682B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.536B | 25.51 |
| PROCEPT BioRobotics (PRCT) | United States | $3.412B | 0.00 |
| Veracyte (VCYT) | United States | $3.181B | 95.46 |
| Nihon Kohden (NHNKY) | Japan | $2.671B | 14.60 |
| LivaNova (LIVN) | United Kingdom | $2.606B | 15.04 |
| TransMedics (TMDX) | United States | $2.532B | 80.27 |
| Elekta AB (EKTAY) | Sweden | $2.336B | 21.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.110B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.700B | 8.88 |
| Alphatec Holdings (ATEC) | United States | $1.512B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.230B | 0.00 |
| RxSight (RXST) | United States | $1.222B | 0.00 |
| Artivion (AORT) | United States | $1.208B | 80.06 |
| OPKO Health (OPK) | United States | $1.140B | 0.00 |
| Paragon 28 (FNA) | United States | $1.093B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.894B | 0.00 |
| AxoGen (AXGN) | United States | $0.814B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.793B | 17.33 |
| SiBone (SIBN) | United States | $0.755B | 0.00 |
| IRadimed (IRMD) | United States | $0.724B | 38.09 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.711B | 12.09 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.692B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.602B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.590B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.497B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.484B | 10.64 |
| ClearPoint Neuro (CLPT) | United States | $0.481B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.429B | 0.00 |
| NeuroPace (NPCE) | United States | $0.425B | 0.00 |
| CVRx (CVRX) | United States | $0.365B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.363B | 19.47 |
| Anteris Technologies Global (AVR) | Australia | $0.297B | 0.00 |
| Inogen (INGN) | United States | $0.245B | 0.00 |
| Accuray (ARAY) | United States | $0.222B | 0.00 |
| Nevro (NVRO) | United States | $0.215B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.201B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.178B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.158B | 0.00 |
| Neuronetics (STIM) | United States | $0.146B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.140B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.129B | 0.00 |
| LENSAR (LNSR) | United States | $0.115B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.101B | 0.00 |
| 908 Devices (MASS) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.091B | 13.90 |
| Lucid Diagnostics (LUCD) | United States | $0.088B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.086B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.081B | 0.00 |
| Hyperfine (HYPR) | United States | $0.078B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.062B | 32.14 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.040B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.028B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.023B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |